Literature DB >> 23621782

Significant differences in cell-cell fusion and viral entry between strains revealed by scanning mutagenesis of the C-heptad repeat of HIV gp41.

Barbara Diaz-Aguilar1, Karen Dewispelaere, Hyun Ah Yi, Amy Jacobs.   

Abstract

The transmembrane subunit, gp41, of the HIV envelope mediates the viral fusion step of entry into the host cell. The protein consists of an extracellular domain, a transmembrane domain, and a cytoplasmic tail. The extracellular domain contains a fusion peptide, an N-terminal heptad repeat, a loop region, a C-terminal heptad repeat (CHR), and a membrane-proximal external region. For this study, we examined each amino acid in the CHR (residues 623-659) by alanine scanning mutagenesis in two HIV strains: one CCR5-utilizing strain (JRFL) and one CXCR4-utilizing strain (HXB2). We studied the functional importance of each amino acid residue by measuring mutational effects in both cell-cell fusion and viral entry and assessing envelope expression and gp120-gp41 proteolytic processing. The transmembrane subunit of the HIV envelope, gp41, is very sensitive to subtle changes, like alanine substitution, which severely affect envelope function at multiple sites. Two important general findings are apparent when the entire data set from this study is taken into account. (1) Strain HXB2 is much more stable to mutagenesis than strain JRFL, and (2) viral entry is much more stable to mutagenesis than cell-cell fusion. These findings strengthen our notion that gp41 is a vulnerable target for therapeutic and prophylactic intervention. Further structural studies aimed at gaining a full understanding of the intermediate states that drive HIV membrane fusion are imperative.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23621782      PMCID: PMC4686141          DOI: 10.1021/bi400201h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  43 in total

1.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

2.  The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure.

Authors:  C Wild; T Greenwell; D Shugars; L Rimsky-Clarke; T Matthews
Journal:  AIDS Res Hum Retroviruses       Date:  1995-03       Impact factor: 2.205

3.  Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins.

Authors:  N Lewis; J Williams; D Rekosh; M L Hammarskjöld
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected.

Authors:  Ema T Crooks; Tommy Tong; Keiko Osawa; James M Binley
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

5.  Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

Authors:  E J Platt; K Wehrly; S E Kuhmann; B Chesebro; D Kabat
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

6.  Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions.

Authors:  Victor Buzon; Ganesh Natrajan; David Schibli; Felix Campelo; Michael M Kozlov; Winfried Weissenhorn
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

7.  A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.

Authors:  K Konopka; E Pretzer; F Celada; N Düzgüneş
Journal:  J Gen Virol       Date:  1995-03       Impact factor: 3.891

8.  A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.

Authors:  C Wild; T Oas; C McDanal; D Bolognesi; T Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

9.  HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.

Authors:  Kosuke Miyauchi; Yuri Kim; Olga Latinovic; Vladimir Morozov; Gregory B Melikyan
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

10.  Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.

Authors:  G B Melikyan; R M Markosyan; H Hemmati; M K Delmedico; D M Lambert; F S Cohen
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more
  7 in total

1.  The membrane proximal external regions of gp41 from HIV-1 strains HXB2 and JRFL have different sensitivities to alanine mutation.

Authors:  Hyun Ah Yi; Barbara Diaz-Rohrer; Priyanka Saminathan; Amy Jacobs
Journal:  Biochemistry       Date:  2015-02-19       Impact factor: 3.162

2.  Efficient replication of a paramyxovirus independent of full zippering of the fusion protein six-helix bundle domain.

Authors:  Melinda A Brindley; Philippe Plattet; Richard Karl Plemper
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

3.  Cell-cell and virus-cell fusion assay-based analyses of alanine insertion mutants in the distal α9 portion of the JRFL gp41 subunit from HIV-1.

Authors:  Mizuki Yamamoto; Qingling Du; Jiping Song; Hongyun Wang; Aya Watanabe; Yuetsu Tanaka; Yasushi Kawaguchi; Jun-Ichiro Inoue; Zene Matsuda
Journal:  J Biol Chem       Date:  2019-02-08       Impact factor: 5.157

4.  The V4 and V5 Variable Loops of HIV-1 Envelope Glycoprotein Are Tolerant to Insertion of Green Fluorescent Protein and Are Useful Targets for Labeling.

Authors:  Shuhei Nakane; Aikichi Iwamoto; Zene Matsuda
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

5.  N-Substituted Pyrrole Derivative 12m Inhibits HIV-1 Entry by Targeting Gp41 of HIV-1 Envelope Glycoprotein.

Authors:  Jiayin Qiu; Taizhen Liang; Junyan Wu; Fei Yu; Xiaoyang He; Yuanxin Tian; Lan Xie; Shibo Jiang; Shuwen Liu; Lin Li
Journal:  Front Pharmacol       Date:  2019-08-02       Impact factor: 5.810

6.  Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations.

Authors:  Yuta Hikichi; Rachel Van Duyne; Phuong Pham; Jennifer L Groebner; Ann Wiegand; John W Mellors; Mary F Kearney; Eric O Freed
Journal:  mBio       Date:  2021-01-12       Impact factor: 7.867

7.  Six-helix bundle completion in the distal C-terminal heptad repeat region of gp41 is required for efficient human immunodeficiency virus type 1 infection.

Authors:  Dehua Liu; Hongyun Wang; Mizuki Yamamoto; Jiping Song; Rui Zhang; Qingling Du; Yasushi Kawaguchi; Jun-Ichiro Inoue; Zene Matsuda
Journal:  Retrovirology       Date:  2018-04-02       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.